Remdesivir Bulk API Mixture from Canada
Remdesivir bulk API mixture is an antiviral for COVID-19 and Ebola treatment, mixed for IV formulation production. Excluded from retail forms, it is classified in HTS 3003.90.0120 as a bulk antiviral.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Monitor FDA import alerts for high-risk antivirals like Remdesivir
• Include viral efficacy studies in documentation; pitfall is missing potency assays
• Ship under controlled temperature with data loggers